| Serial Number | 98625063 |
| Word Mark | REGENERON CELL MEDICINES |
| Filing Date | Thursday, July 4, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, September 16, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 16, 2025 |
| Goods and Services | Pharmaceutical preparations and substances for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; genetically modified cells, genome editing reagents and biological preparations, namely, viral vectors, all for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer |
| NOT AVAILABLE | "CELL MEDICINES" |
| Goods and Services | Pharmaceutical research and development services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 4, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 4, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Regeneron Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Tarrytown, NY 10591 |
| Party Name | Regeneron Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Tarrytown, NY 10591 |
| Event Date | Event Description |
| Thursday, July 4, 2024 | NEW APPLICATION ENTERED |
| Tuesday, January 14, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 29, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 29, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 29, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, January 16, 2025 | ASSIGNED TO EXAMINER |
| Monday, April 21, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 21, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 21, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 10, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 16, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 16, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, August 14, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, June 30, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, June 30, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, June 30, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |